Condition
Locally Advanced/ Metastatic NSCLC
Total Trials
2
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
Treatment Research
2 treatments under study, led by Sotorasib
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Unknown2
Clinical Trials (2)
Research Network
Common Treatments
- Sotorasib1
- Vinorelbine1
Active Sponsors
- Azienda Sanitaria Ospedaliera1
- International Group of Endovascular Oncology1
- Amgen1
Related Conditions
- Locally Advanced Unresectable Nsclc1
- Non Smallcell Lung Cancer1